Crescent Biopharma, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $240.3M
Liabilities Breakdown FY2025
Total Liabilities: $37.3M
Asset Breakdown
Total Assets: $240.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $213.2M | 88.7% |
| Accounts Receivable | $18.0M | 7.5% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $846.0K | 0.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $8.3M | 3.4% |
Liabilities Breakdown
Total Liabilities: $37.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $37.3M | 100.0% |